AngioDynamics (ANGO) Fundamental Analysis: Revenue, Earnings & Valuation

9.99 / 10

Outperform

Fundamentals receive an Outperform rating with a 10/10 profile. Asset‑MV and Profit‑MV are strong, while Revenue‑MV and Cash‑MV lag. ROA and profit margins are modestly negative, yet the net‑profit‑to‑total‑profit ratio is near 100%, indicating solid earnings quality.

Analysis Checks(5/10)

Revenue-MV

Value-0.02

Score0/3

Weight-2456.10%

1M Return-4.18%

ROA (%)

Value-11.37

Score1/3

Weight-511.89%

1M Return-0.82%

Net cash flow from operating activities / Operating revenue (%)

Value-3.46

Score1/3

Weight-807.20%

1M Return-1.35%

Profit-MV

Value0.66

Score2/3

Weight2319.69%

1M Return3.09%

Annualized net profit margin on total assets (%)

Value-11.37

Score1/3

Weight-511.89%

1M Return-0.82%

EBIT / Total operating revenue (%)

Value-11.97

Score2/3

Weight69.36%

1M Return0.10%

Asset-MV

Value-1.11

Score3/3

Weight3523.62%

1M Return4.62%

Net profit / Total operating revenue (%)

Value-11.62

Score3/3

Weight1032.80%

1M Return1.41%

Cash-MV

Value-0.02

Score1/3

Weight-2198.97%

1M Return-4.16%

Net profit / Total profit (%)

Value99.89

Score2/3

Weight-359.42%

1M Return-0.54%

Is ANGO undervalued or overvalued?

ANGO scores 9.99/10 on fundamentals and holds a Discounted valuation at present. Backed by its -9.60% ROE, -9.02% net margin, -16.17 P/E ratio, 2.54 P/B ratio, and 88.01% earnings growth, these metrics solidify its Outperform investment rating.